Go Pro
OTCMKTS:MCUJF

Medicure (MCUJF) Stock Price, News & Analysis

Medicure logo
$1.90 0.00 (0.00%)
As of 02:46 PM Eastern

About Medicure Stock (OTCMKTS:MCUJF)

Advanced

Key Stats

Today's Range
$1.88
$1.91
50-Day Range
$0.67
$1.93
52-Week Range
$0.67
$1.93
Volume
10,320 shs
Average Volume
15,151 shs
Market Capitalization
$19.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medicure Inc. is a Winnipeg, Manitoba-based specialty pharmaceutical company focused on developing, commercializing and distributing therapies for cardiovascular and related medical conditions. The company serves healthcare markets primarily in North America through its operating subsidiaries and commercial partners.

Medicure’s product portfolio includes AGGRASTAT (tirofiban hydrochloride), an intravenous antiplatelet medication used in the treatment of certain patients with acute coronary syndrome and during percutaneous coronary intervention. The company also markets ZYPITAMAG (pitavastatin), an oral statin used to help manage elevated cholesterol levels.

Medicure has historically concentrated on specialty cardiovascular products and has sought to expand its presence through product development, licensing and commercialization activities. The company is led by Dr. Albert D. Friesen, who serves as president and chief executive officer.

AI Generated. May Contain Errors.

Receive MCUJF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MCUJF Stock News Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
Medicure Inc. (MCUJF) Q4 2024 Earnings Call Transcript
See More Headlines

MCUJF Stock Analysis - Frequently Asked Questions

Medicure's stock was trading at $0.7997 at the beginning of the year. Since then, MCUJF shares have increased by 137.6% and is now trading at $1.90.

Medicure Inc. (OTCMKTS:MCUJF) announced its earnings results on Friday, August, 14th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.05. The company earned $5.36 million during the quarter, compared to analyst estimates of $2.45 million. Medicure had a negative trailing twelve-month return on equity of 54.55% and a negative net margin of 23.14%.

Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/14/2026
Today
9/21/2026
Next Earnings (Estimated)
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MCUJF
CIK
1133519
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.08 million
Net Margins
-23.14%
Pretax Margin
-22.54%
Return on Equity
-54.55%
Return on Assets
-30.42%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
0.97
Quick Ratio
0.64

Sales & Book Value

Annual Sales
$20.65 million
Price / Sales
0.96
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.89 per share
Price / Book
2.13

Miscellaneous

Outstanding Shares
10,440,000
Free Float
9,090,000
Market Cap
$19.84 million
Optionable
Not Optionable
Beta
1.15
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:MCUJF) was last updated on 9/21/2026 by MarketBeat.com Staff.
From Our Partners